T1	Participants 43 91	male patients with diffuse large B-cell lymphoma
T2	Participants 364 511	321 patients [161 randomized to the treatment group (TG), 160 to the observation group (OG)], 295 data sets were evaluable for statistical analysis
T3	Participants 1115 1122	females
T4	Participants 1128 1133	males
